Use of 18-methyl-15b, 16b-methyl-15b, 16b-methyl-19-nor-20-helix-4-en-3-onas and intrauterine system including 18-methyl-15b, 16b-methyl-19-nor-20-helix-4-en-3-onas to treat uterine bleeding during menopause
SCHMEES, NORBERT,ROSE, LARS,VALO, TUULA,PRELLE, KATJA,NUBBEMEYER, REINHARD,KOROLAINEN, HENRIIKKA,JUKARAINEN, HARRI
申请号：
PE2014001785
公开号：
PE20142437A1
申请日:
2013.04.19
申请国别(地区):
PE
年份:
2015
代理人:
摘要：
The compounds are from 18-methyl-15 (β), 16 (β) - methyl-19-nor-20-helix-4-in-3-formaldehyde (1), R6 and R7 are hydrogen or a methylene group. It also relates to an intrauterine system including formula 1. These compounds are useful in the treatment of menopause, general intrauterine bleeding and so on.Referida a un compuesto derivado de 18-metil-15(beta),16(beta)-metilen-19-nor-20-espirox-4-en-3-onas de formula general (1), donde R6 y R7 son hidrogeno o un grupo metileno. Tambien esta referida a un sistema intrauterino que comprende el compuesto de formula 1. Dichos compuestos son utiles en el tratamiento de la menorragia, de hemorragias intrauterinas en general, entre otros
